Cardinal Health Inc.: Xolair (omalizumab injection), 75 mg/0.5 ml
Recall reason: CGMP Deviations - Product was exposed to temperatures outside the product's labeled storage requirements.. Recalled by Cardinal Health Inc.. Distribution: Nationwide Within the U.S.. Classification (Class II — potential health risk). Affected lots/NDC/dates: Lot: 3630004, Expires: 10/31/2025.. Return the recalled medication to the pharmacy where you purchased it for a full refund of the purchase price.
📬 Get email alerts for new Product Recalls & Refunds
Free — we'll email you when new matching opportunities appear. No spam, unsubscribe anytime.
New here? Here's how Reward Opportunity works:
🔔 More Product Recalls & Refunds
Product recalls offering refunds, replacements, or repairs to consumers who purchased the item.
Browse all product recalls & refunds →Not just this one — find everything you qualify for
Our AI scans 8,000+ bounties, settlements, grants, recalls, and paid studies against your profile to rank what you can actually claim.
Get My Free Match Report